Topic Hub

How Inclisiran Affects Labs

2 clinically reviewed articles, written and peer-reviewed by the HealthRX Medical Team.

2articles

19keywords mapped

2026-05-26latest review

Explore

How Inclisiran Affects Labs library

Showing 2 of 2 clinical reviews.

Dosing & Monitoring2026-05-26

Does Leqvio (Inclisiran) Affect Lp(a)? Clinical Evidence and Monitoring

Inclisiran (Leqvio) modestly reduces Lp(a) by 15 to 20% through PCSK9 silencing. Review of ORION trial data, mechanism, monitoring timing, and clinical significance for cardiovascular risk.

Read clinical review

Questions2026-05-26

How Does Inclisiran (Leqvio) Affect ApoB Levels?

Inclisiran (Leqvio) reduces apolipoprotein B (ApoB) by approximately 25-27% in phase 3 ORION trials. Learn the mechanism, magnitude, time course, and monitoring recommendations for ApoB on inclisiran therapy.

Read clinical review